Education
About Us
Working with TipRanks
Follow Us
Dr. Lal PathLabs Limited (IN:LALPATHLAB)
:LALPATHLAB
RESEARCH TOOLSreports
Total Valuation
Dr. Lal PathLabs Limited has a market cap or net worth of ₹235.19B. The enterprise value is ―.
Market Cap₹235.19B
Enterprise Value―
Share Statistics
Dr. Lal PathLabs Limited has 83,591,736 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding83,591,736
Owned by Insiders―
Owned by Institutions0.08%
Financial Efficiency
Dr. Lal PathLabs Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Dr. Lal PathLabs Limited is ―. Dr. Lal PathLabs Limited’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Dr. Lal PathLabs Limited had revenue of 22.27B and earned 3.58B in profits. Earnings per share was 43.05.
Revenue22.27B
Gross Profit12.79B
Operating Income8.65B
Pretax Income5.05B
Net Income3.58B
EBITDA6.78B
Earnings Per Share (EPS)43.05
Cash Flow
In the last 12 months, operating cash flow was 1.44B and capital expenditures 0.00, giving a free cash flow of 1.44B billion.
Operating Cash Flow1.44B
Free Cash Flow1.44B
Free Cash Flow per Share17.20
Dividends & Yields
Dr. Lal PathLabs Limited pays an annual dividend of ₹24, resulting in a dividend yield of 0.85%
Dividend Per Share₹24
Dividend Yield0.85%
Payout Ratio9.39%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.72
52-Week Price Change13.32%
50-Day Moving Average2.61K
200-Day Moving Average2.96K
Relative Strength Index (RSI)54.51
Average Volume (3m)19.04K
Important Dates
Dr. Lal PathLabs Limited upcoming earnings date is Jul 24, 2025, TBA Not Confirmed.
Last Earnings DateApr 25, 2025
Next Earnings DateJul 24, 2025
Ex-Dividend DateJun 06, 2025
Financial Position
Dr. Lal PathLabs Limited as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Dr. Lal PathLabs Limited has paid 1.43B in taxes.
Income Tax1.43B
Effective Tax Rate―
Enterprise Valuation
Dr. Lal PathLabs Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Dr. Lal PathLabs Limited has ₹9.43B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹9.43B billion.
Cash & Marketable Securities₹9.43B
Total Debt₹0.00
Net Cash-₹9.43B
Net Cash Per Share-₹112.76
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Dr. Lal PathLabs Limited is ₹3,107.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹3,107.50
Price Target Upside6.91% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―